Topics

ABIVAX Company Profile

22:07 EDT 15th September 2019 | BioPortfolio


News Articles [22 Associated News Articles listed on BioPortfolio]

Abivax: Frisches Kapital eingesammelt

Kulmbach (www.aktiencheck.de) - Abivax-Aktienanalyse vom Anlegermagazin "Der Aktionär": Michel Doepke von "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von Abivax SA (ISIN: FR0012....

ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price

Abivax cash runway extended to end of Q2, 2020 - Sofinnova Partners strengthens and diversifies Abivax shareholder base - Sofinnova Partners to join the Board of Directors - Proceeds to be used fo...

Abivax SA (ABVX-FR): ABX464: sustained safety and -2-

DJ Abivax SA (ABVX-FR): ABX464: sustained safety and benefit in inflammatory bowel Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Abivax...

Abivax's Lead Asset: A Pipeline In Itself?

Shares of French biotechnology company Abivax SA (ABVX.PA), which hit a 52-week low of EUR 5.20 on October 26, 2018, have since gained 64 percent.

DGAP-News: ABIVAX: Studienergebnisse (deutsch)

Abivax präsentierte 9-Monats-Daten der Phase-2a-Erhaltungsstudie mit ABX 464 in Colitis ulcerosa, die eine langfristige Wirksamkeit und Sicherheit zeigen, auf führender internationaler Konferenz fü...

Abivax: Im Wettlauf mit MorphoSys wohl chancenlos!

Wie das kleine französische Biotechnologie-Unternehmen Abivax (WKN: A14UQC) gestern Abend per Ad hoc-Meldung bekannt gab, hat man eine klinische Phase-2a-Studie mit seinem Medikamenten-Kandidaten A.....

Abivax secures FDA approval for Phase I/II trial with ABX196 in HCC

Abivax and Scripps Research have secured approval from the US Food and Drug Administration (FDA) to start a Phase I/II...Read More... The post Abivax secures FDA approval for Phase I/II trial with ABX...

DGAP-News: Abivax Kapitalerhöhung in Höhe von EUR 12 Millionen vollständig von Sofinnova Partners zum Marktpreis gezeichnet (deutsch)

Abivax Kapitalerhöhung in Höhe von EUR 12 Millionen vollständig von Sofinnova Partners zum Marktpreis gezeichnet DGAP-News: ABIVAX / Schlagwort(e): Kapitalmaßnahme Abivax Kapitalerhöhung in Höhe...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "ABIVAX" on BioPortfolio

We have published hundreds of ABIVAX news stories on BioPortfolio along with dozens of ABIVAX Clinical Trials and PubMed Articles about ABIVAX for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ABIVAX Companies in our database. You can also find out about relevant ABIVAX Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record